Abstract:Zi-Qi Li, &ast Guo-Song Zhang, &ast Ri-Qun Liu, Shu-Yuan Shuai, Peng-Yi Hu, Qin Zheng, Shu-Hua Xiao Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, 330004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Peng-Yi Hu; Qin Zheng, Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, 330004, People's Republic of China, Tel/Fax +86 0791 87118658, Email ; Background: Ligustilide (LIG) and n-butylphthalide (NBP) have neuroprotective effects in cerebral ischemia; however, their roles in gliomas are not well-known.This study aimed to explore the anti-glioma effects of LIG and NBP individually and the synergistic effects of temozolomide (TMZ) via the PI3K/Akt Signaling Pathway. Materials and Methods: Cytotoxicity of LIG and NBP alone and in combination with TMZ in U251 cells was determined using the CCk-8. The effect of compounds alone or in combination on cell migration was detected using the wound healing assay, and the invasion was evaluated by transwell assays, respectively. Cell apoptosis was quantified by flow cytometry and the changed expressions of proteins were detected by Western blotting. Results: The results showed that LIG and NBP significantly inhibited the growth of U251 cells at concentrations of 4– 10 μg/mL and 1.5– 6 μg/mL in a dose-dependent manner ( p < 0.05, p < 0.01). The combination of 20 μg/mL TMZ with LIG in the concentration range of 4– 10 μg/mL or with NBP of 0.5– 6 μg/mlachieved synergistic effect towardsU251 cells. LIG and NBP, alone or in combination with TMZ, markedly inhibited cell invasion ( p < 0.001) and enhanced apoptosis ( p < 0.05). The combination of TMZ with LIG or NBP markedly inhibited cell migration ( p < 0.001). Western blot analysis showed that LIG, NBP, and TMZ, alone and in combination, significantly decreased the expression of Bcl-2, p-PI3K, and p-Akt, and increased the expression of Bax. Conclusion: Both LIG and NBP exert anti-glioma effects on their own through the PI3K/Akt pathway and enhance TMZ-mediated anti-glioma efficiency via the same pathway. Keywords: ligustilide, n-butylphthalide, glioma, synergistic effect, PI3K/Akt signaling pathway Graphical Glioblastoma (GBM) is the most common and aggressive primary brain tumor, with a median survival of less than one year. 1 In the past 30 years, the incidence of glioma has been increasing at a rate of 1–2% per year. 2 Current approaches to therapy include surgery, radiotherapy, and chemotherapy, as well as emerging gene therapy and immunotherapy in recent years; however, the results are unsatisfactory. 3 Temozolomide (TMZ) is an oral alkylating agent and has been widely applied as an effective first-line chemotherapeutic agent for the treatment of glioma patients. 4 However, TMZ resistance is one of the main reasons for glioma treatment failure. Drug combinations are one of the effective means to alleviate drug resistance and improve therapeutic effect of glioma, 5 such as the combination of TMZ with an inhibitor of histone methyltransferase G9a BIX01294, 6 and the combination of TMZ with a prototype cyclooxygenase (COX-2) inhibitor NS-398. 7 The mechanism of the resistance to TMZ is various within the same tumor, and therefore it is a challenge to select which drug is compatible with TMZ. Chuanxiong ( Ligusticum chuanxiong Hort., Umbelliferae), a commonly used Chinese medicinal herb with hemodynamic and analgesic effects, has also been used in traditional Chinese medicine compound prescriptions to treat brain tumors, such as the Wenyang Tongqiao decoction, 8 JiuweiTongqiao decoction, 9 Naoliu power, 10 XuefuZhuyu decoction. 11 The essential oil of chuanxionginhibited glioma angiogenesis, cell migration, and invasion via the EGFR/VEGF-A signaling pathway. 12 Our previous research also showed that chuanxiong essential oil could enhanceTMZ-induced anti-cancer efficiency in vivo. 13 As the largest proportion of chuanxiong essential oil, phthalide contains a large amount of ligustilide (LIG) and n-butylphthalide (NBP); 14 its chemical structure is shown in Figure 1. LIG significantly reduced T98G cells' migration, 15 inhibited the secretion of vascular endothelial growth factor A (VEGFA) from prostate cancer-related fibroblasts. 16 Interestingly, LIG showed little cytotoxicity to normal hepatocytes but restrained cell proliferation and -Abstract Truncated-

Ligustilide Induces Apoptosis and Reduces Proliferation in Human Bladder Cancer Cells by NFκB1 and Mitochondria Pathway

Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion

Lobaplatin induces apoptosis in T24 and 5637 bladder cancer cells by regulating Bcl-2 and Bax expression and inhibiting the PI3K/Akt signaling pathway

CB-5083 and luteolin synergistically induce apoptosis of bladder cancer cells via multiple mechanisms

Ligustrazine Induces Apoptosis of Breast Cancer Cells in Vitro and in Vivo

Ligustilide inhibits the proliferation of non-small cell lung cancer via glycolytic metabolism

Effects of Ligustilide on Tumor Growth and Immune Function in Institute of Cancer Research Mice

Baicalein Inhibits The Invasion, Migration And Epithelial-Mesenchymal Transition Of Bgc-823 Cells Through Nf-Kappa B/Snail Signaling Pathway

Liriopesides B Induces Apoptosis and Cell Cycle Arrest in Human Non‑small Cell Lung Cancer Cells.

Ligustilide attenuates nitric oxide-induced apoptosis in rat chondrocytes and cartilage degradation via inhibiting JNK and p38 MAPK pathways.

Echinatin Inhibits Tumor Growth and Synergizes with Chemotherapeutic Agents Against Human Bladder Cancer Cells by Activating P38 and Suppressing Wnt/β-catenin Pathways

Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells

Medicarpin induces G1 arrest and mitochondria-mediated intrinsic apoptotic pathway in bladder cancer cells

Anticancer Activity of Luteolin and Its Synergism Effect with BCG on Human Bladder Cancer Cell Line BIU-87

Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway

Downregulation of LAPTM5 Suppresses Cell Proliferation and Viability Inducing Cell Cycle Arrest at G0/G1 Phase of Bladder Cancer Cells

BET Inhibitor JQ1 Suppresses Cell Proliferation Via Inducing Autophagy and Activating LKB1/AMPK in Bladder Cancer Cells.

Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis.

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing

Ipatasertib (GDC-0068) and Erdafitinib Co-Treatment for Inducing Mitochondrial Apoptosis Through Bim Upregulation in Bladder Cancer Cells

Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway